NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.)'s (NBY) CEO, Dr. Ron Najafi, Joins Distinguished Leaders Selected for This Year’s PharmaVOICE 100 Most Influential Leaders

EMERYVILLE, Calif.--(BUSINESS WIRE)--Ron Najafi, PhD, Chief Executive Officer and Chairman of Emeryville, CA-based NovaBay Pharmaceuticals (AMEX & TSX: NBY, http://www.novabaypharma.com), a clinical stage biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial, fungal, and viral infections, was chosen as one of the “PharmaVOICE 100,” most influential leaders. “PharmaVOICE 100” is an annual list of individuals who are having a remarkable influence on the life sciences industry.